NO DIFFERENCES IN EFFECTIVENESS OF TNF BLOCKERS FOR RA
This month we are highlighting a study published in RHEUMATOLOGY, led by Drs. Canhao and Solomon regarding the comparative effectiveness of TNF blockers for rheumatoid arthritis. There have been almost no head to head randomized controlled trials between the TNF blockers and so clinicians and patient rely on observational comparative effectiveness studies to determine the best treatment options for RA. The authors examined a large and detailed database from Portugal to compare the treatment response across adalimumab, etanercept and infliximab. After conducting the analyses in several different manners, the results consistently demonstrated no differences in effectiveness.
For more information, visit:
Send Feedback to: Danielle Gillmer
This page was last modified on 11/12/2013